Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported mixed fourth-quarter results on Wednesday, with revenue surpassing expectations while adjusted earnings missed analyst forecasts and full-year guidance came in below consensus estimates. Shares rose 1.40% in pre-market trading following the announcement.
The behavioral healthcare provider generated fourth-quarter revenue of $821.5 million, representing a 6.1% year-over-year increase and exceeding the analyst consensus estimate of $801.93 million.
Adjusted earnings per share totaled $0.07, however, falling short of the $0.10 expected by analysts. The company reported a net loss of -$13.02 per diluted share, compared with net income of $0.35 per share in the prior-year period, primarily due to a $996.2 million non-cash goodwill impairment charge.
For fiscal 2026, Acadia projected adjusted EPS in a range of $1.30 to $1.55, with the midpoint of $1.43 significantly below the consensus estimate of $1.71.
The company expects full-year revenue between $3.37 billion and $3.45 billion, with the midpoint of $3.41 billion slightly above analyst expectations of $3.4 billion. First-quarter guidance includes adjusted EPS of $0.25 to $0.30, with a midpoint of $0.28 in line with consensus, while projected revenue of $820 million to $830 million exceeded the $806.6 million estimate.
“Our results for the fourth quarter reflect improved volume growth with year-over-year revenue growth of 6%,” said Chief Executive Officer Debbie Osteen. “While we work to address the ongoing challenges affecting our business, my key priorities as CEO are to bring steady leadership, reinforce operational discipline, and help position the Company for long-term success.”
Adjusted EBITDA for the quarter was $99.8 million, down 35% from $153.1 million a year earlier, largely reflecting a $52.7 million adjustment related to professional and general liability reserves.
Same-facility revenue increased 4.4%, supported by a 3.1% rise in patient days and a 1.3% increase in revenue per patient day.